HAEGARDA
HAEGARDA
Approved
DIN Number
02468069
Drug Class
Human
Market Date
Jan 23, 2020
Company
HC
csl behring canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02468069
AIG Number0152746003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B06AC01 C1-INHIBITOR, PLASMA DERIVED
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationSubcutaneous
AHFS Classification92:32.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
C1 ESTERASE INHIBITOR (HUMAN)Active
Strength: 2000 UNIT / VIAL
Monograph: C1 ESTERASE INHIBITOR (HUMAN)